Compugen (CGEN) Cash & Equivalents Growth (3y) (2012 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 36.53% |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 101.59% |
| Jun 30, 2025 | -8.24% |
| Dec 31, 2024 | 32.70% |
| Jun 30, 2024 | 14.82% |
| Dec 31, 2023 | 24.82% |
| Jun 30, 2023 | 10.98% |
| Dec 31, 2022 | 6.38% |
| Jun 30, 2022 | 10.35% |
| Dec 31, 2021 | 6.46% |
| Jun 30, 2021 | -10.48% |
| Dec 31, 2020 | -34.54% |
| Jun 30, 2020 | -9.61% |
| Dec 31, 2019 | -1.83% |
| Jun 30, 2019 | -16.70% |
| Dec 31, 2018 | -15.66% |
| Jun 30, 2018 | -24.72% |
| Dec 31, 2017 | -0.23% |
| Jun 30, 2017 | -16.21% |
| Dec 31, 2016 | -30.36% |
| Jun 30, 2016 | -6.29% |
| Dec 31, 2015 | -13.01% |
| Jun 30, 2015 | 42.90% |
| Dec 31, 2014 | 63.70% |
| Jun 30, 2014 | 57.92% |
| Dec 31, 2013 | 57.92% |
| Jun 30, 2013 | -4.72% |
| Dec 31, 2012 | 2.65% |
| Jun 30, 2012 | 23.63% |